| Literature DB >> 26411587 |
Abstract
A systems-based investigation of the effect of perturbations on metabolic machinery is crucial to elucidate the mechanism behind perturbations. One way to investigate the perturbation-induced changes within the cell metabolism is to focus on pathway-level effects. In this study, three different perturbation types (genetic, environmental and disease-based) are analyzed to compute a list of reporter pathways, metabolic pathways which are significantly affected from a perturbation. The most common omics data type, transcriptome, is used as an input to the bioinformatic analysis. The pathways are scored by two alternative approaches: by averaging the changes in the expression levels of the genes controlling the associated reactions (reaction-centric), and by averaging the changes in the associated metabolites which were scored based on the associated genes (metabolite-centric). The analysis reveals the superiority of the novel metabolite-centric approach over the commonly used reaction-centric approach since it is based on metabolites which better represent the cross-talk among different pathways, enabling a more global and realistic cataloguing of network-wide perturbation effects.Entities:
Mesh:
Year: 2015 PMID: 26411587 PMCID: PMC4585941 DOI: 10.1038/srep14563
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Significantly perturbed pathways for GDH1 deletion in S. cerevisiae.
| Pathway | Number of metabolite neighbors | p-value (RPAm) | Number of reaction neighbors | p-value (RPAr) |
|---|---|---|---|---|
| superpathway of leucine, valine, and isoleucine biosynthesis | 24 | 3.44E-06 | 6 | 1.75E-02 |
| superpathway NAD/NADP - NADH/NADPH interconversion | 19 | 8.36E-06 | 5 | 4.62E-03 |
| leucine biosynthesis | 12 | 9.95E-06 | 3 | 8.27E-03 |
| pentose phosphate pathway | 14 | 2.98E-05 | 6 | 4.36E-02 |
| glyoxylate cycle | 13 | 3.23E-05 | 5 | 3.67E-02 |
| TCA cycle, aerobic respiration | 23 | 4.70E-05 | 9 | 8.84E-03 |
| NAD/NADP-NADH/NADPH cytosolic interconversion | 15 | 9.41E-05 | 4 | 7.27E-03 |
| threonine degradation | 9 | 2.08E-04 | 3 | 2.04E-02 |
| dolichyl-diphosphooligosaccharide biosynthesis | 23 | 3.08E-04 | 11 | |
| gluconeogenesis | 21 | 5.11E-04 | 11 | |
| citrulline biosynthesis | 23 | 6.11E-04 | 7 | |
| valine degradation | 10 | 6.20E-04 | 3 | 4.15E-02 |
| superpathway of heme biosynthesis | 18 | 8.31E-04 | 8 | |
| chitin biosynthesis | 33 | 8.82E-04 | 14 | 1.91E-02 |
| isoleucine degradation II | 10 | 1.06E-03 | 3 | 4.15E-02 |
| isoleucine degradation | 10 | 1.06E-03 | 3 | 4.15E-02 |
| pentose phosphate pathway (non-oxidative branch) | 7 | 1.39E-03 | 4 | |
| tetrapyrrole biosynthesis II | 11 | 1.47E-03 | 4 | |
| tetrapyrrole biosynthesis | 11 | 1.47E-03 | 4 | |
| isoleucine biosynthesis | 13 | 1.52E-03 | 4 | |
| glycolysis III (glucokinase) | 18 | 1.79E-03 | 10 | |
| superpathway of serine and glycine biosynthesis I | 14 | 2.00E-03 | 4 | |
| glycolysis | 17 | 2.47E-03 | 9 | |
| 2-ketoglutarate dehydrogenase complex | 10 | 2.48E-03 | 3 | |
| homocysteine and cysteine interconversion | 8 | 2.58E-03 | 3 | |
| folate transformations | 20 | 2.65E-03 | 7 | |
| leucine degradation III | 10 | 3.73E-03 | 3 | |
| leucine degradation | 10 | 3.73E-03 | 3 | |
| NAD/NADP-NADH/NADPH mitochondrial interconversion | 12 | 4.01E-03 | 3 | 1.75E-02 |
| serine biosynthesis from 3-phosphoglycerate | 11 | 5.15E-03 | 3 | |
| octanoyl-ACP biosynthesis (mitochondria) | 20 | 5.31E-03 | 6 | |
| superpathway of allantoin degradation in yeast | 13 | 5.36E-03 | 4 | |
| valine biosynthesis | 12 | 5.53E-03 | 4 | |
| lysine biosynthesis | 22 | 7.47E-03 | 6 | |
| folate interconversions | 22 | 7.58E-03 | 8 |
Pathways with RMAm p-value lower than 0.01 are listed. RPAr p-values greater than 0.05 are given in bold for a better demonstration of pathways not captured by RPAr.
Significantly perturbed pathways for aerobic-anaerobic change in S. cerevisiae.
| Pathway | Number of metabolite neighbors | p-value (RPAm) | Number of reaction neighbors | p-value (RPAr) |
|---|---|---|---|---|
| 10-trans-heptadecenoyl-CoA degradation (reductase-dependent) | 19 | 6.02E-08 | 5 | 1.06E-03 |
| 10-cis-heptadecenoyl-CoA degradation | 19 | 9.89E-08 | 5 | 1.06E-03 |
| 9-cis, 11-trans-octadecadienoyl-CoA degradation (isomerase-dep.) | 18 | 2.97E-07 | 4 | 2.09E-03 |
| aerobic respiration (cytochrome c) | 13 | 1.69E-05 | 4 | 8.71E-03 |
| aerobic respiration (linear view) | 13 | 1.69E-05 | 4 | 8.71E-03 |
| fatty acid oxidation (non-cyclic) | 18 | 5.23E-05 | 5 | 6.59E-04 |
| fatty acid beta-oxidation (peroxisome) | 16 | 1.31E-04 | 4 | 5.03E-03 |
| tryptophan degradation VIII (to tryptophol) | 10 | 1.96E-04 | 3 | 2.56E-03 |
| gluconeogenesis | 21 | 2.38E-04 | 11 | 2.71E-03 |
| glycolysis III (glucokinase) | 18 | 3.47E-04 | 10 | 3.83E-03 |
| glycolysis | 17 | 4.39E-04 | 9 | 8.73E-03 |
| glyoxylate cycle | 13 | 6.54E-04 | 5 | 7.01E-03 |
| sphingolipid biosynthesis | 24 | 8.04E-04 | 8 | 2.60E-02 |
| ethylene biosynthesis | 12 | 1.10E-03 | 3 | 4.79E-02 |
| oleate beta-oxidation (reductase-dependent) | 7 | 1.16E-03 | 3 | 1.69E-02 |
| superpathway phosphatidate biosynthesis (yeast) | 12 | 2.04E-03 | 4 | |
| superpathway of leucine, valine, and isoleucine biosynthesis | 24 | 2.40E-03 | 6 | |
| superpathway NAD/NADP - NADH/NADPH interconversion | 19 | 3.17E-03 | 6 | |
| zymosterol biosynthesis | 22 | 3.89E-03 | 5 | |
| phenylalanine degradation | 12 | 4.00E-03 | 4 | 3.52E-03 |
| heme biosynthesis | 11 | 4.13E-03 | 4 | 1.59E-03 |
| pentose phosphate pathway | 14 | 5.25E-03 | 6 | |
| TCA cycle, aerobic respiration | 23 | 5.38E-03 | 9 | |
| chitin degradation to ethanol | 20 | 6.78E-03 | 6 | 8.63E-03 |
| NAD/NADP-NADH/NADPH cytosolic interconversion | 15 | 7.98E-03 | 4 | |
| tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde | 13 | 8.19E-03 | 5 | 1.25E-02 |
Pathways with RMAm p-value lower than 0.01 are listed. RPAr p-values greater than 0.05 are given in bold for a better demonstration of pathways not captured by RPAr.
Significantly perturbed pathways for Alzheimer’s disease.
| Pathway | Number of metabolite neighbors | p-value (RPAm) | Number of reaction neighbors | p-value (RPAr) |
|---|---|---|---|---|
| triacylglycerol biosynthesis | 10 | 1.58E-06 | 4 | 5.10E-03 |
| terminal O-glycans residues modification | 19 | 1.97E-05 | 7 | 2.38E-02 |
| pyrimidine deoxyribonucleotides | 19 | 7.20E-05 | 5 | |
| CDP-diacylglycerol biosynthesis | 12 | 8.87E-05 | 4 | |
| phosphatidylcholine biosynthesis | 11 | 1.59E-04 | 3 | |
| D-myo-inositol (1,4,5)-trisphosphate biosynthesis | 12 | 1.79E-04 | 4 | 4.38E-02 |
| pyrimidine deoxyribonucleotides biosynthesis from CTP | 17 | 2.51E-04 | 5 | |
| chondroitin sulfate biosynthesis (late stages) | 12 | 4.66E-04 | 4 | 6.82E-03 |
| retinol biosynthesis | 15 | 2.00E-03 | 6 | |
| 3-phosphoinositide biosynthesis | 15 | 2.15E-03 | 7 | 2.74E-02 |
| phospholipases | 11 | 2.17E-03 | 4 | |
| gluconeogenesis | 29 | 2.78E-03 | 12 | |
| TCA cycle | 31 | 3.53E-03 | 8 | |
| CMP-N-acetylneuraminate biosynthesis I (eukaryotes) | 16 | 5.16E-03 | 4 | |
| melatonin degradation I | 15 | 6.81E-03 | 3 | |
| sphingosine and sphingosine-1-phosphate metabolism | 9 | 6.99E-03 | 3 | 3.74E-02 |
| mevalonate pathway | 17 | 7.20E-03 | 7 | |
| 4-hydroxyproline degradation | 14 | 9.04E-03 | 3 | |
| D-myo-inositol-5-phosphate metabolism | 8 | 9.35E-03 | 3 | |
| heparan sulfate biosynthesis (late stages) | 22 | 9.54E-03 | 9 |
Pathways with RMAm p-value lower than 0.01 are listed. RPAr p-values greater than 0.05 are given in bold for a better demonstration of pathways not captured by RPAr.
Figure 1Comparison of reaction-centric and metabolite-centric reporter pathway analysis approaches.
While the change in the gene activities corresponding to reactions R4, R5, R6 and R8 are not counted in RPAr (reaction-centric reporter pathway analysis) since they are categorized under other pathways, they are considered in RPAm (metabolite-centric reporter pathway analysis) since the metabolites of the pathway are interdependent with the rates of these reactions. (Mi: metabolites, Ri: reactions, gi: genes, pi: p-values).